FCMV
Foresite Capital Management V Portfolio holdings
AUM
$80.7M
This Quarter Return
+3.72%
1 Year Return
-24.46%
3 Year Return
+66.81%
5 Year Return
–
10 Year Return
–
AUM
$80.7M
AUM Growth
+$80.7M
(-7.9%)
Cap. Flow
-$64.5M
Cap. Flow
% of AUM
-79.94%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
1
Reduced
1
Closed
–
Top Buys
| 1 |
CG Oncology
CGON
|
$3.77M |
Top Sells
| 1 |
Lyell Immunopharma
LYEL
|
$68.3M |
Sector Composition
| 1 | Healthcare | 83.13% |
| 2 | Consumer Staples | 16.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
CG Oncology
CGON
$2.04B
| $26.1M | 32.34% | 1,004,050 +145,000 | +17% | +$3.77M |
|
|
ALMS
2
Alumis Inc. Common Stock
ALMS
$479M
| $17.3M | 21.48% | 5,779,348 | – | – |
|
3
Disc Medicine
IRON
$2.07B
| $15.8M | 19.62% | 299,069 | – | – |
|
4
Hims & Hers Health
HIMS
$9.57B
| $13.6M | 16.87% | 273,151 | – | – |
|
|
MAZE
5
Maze Therapeutics, Inc. Common Stock
MAZE
$635M
| $4.24M | 5.25% | 345,191 | – | – |
|
|
6
Lyell Immunopharma
LYEL
$213M
| $3.59M | 4.45% | 406,652 -7,726,395 | -95% | -$68.3M |
|